The Biden Administration set a November 30, 2023 deadline for Venezuela’s criminal Maduro narco-regime to release U.S. hostages and enable opposition leader María Corina Machado, who had a landslide victory in October’s primary elections, to run against Maduro in the...
Last month, American autoworkers secured big wins through negotiations with the “Big Three” automakers. Automakers have historically threatened to offshore manufacturing jobs and production to cut costs, even while they receive generous benefits from the American tax...
U.S. Senator Marco Rubio’s (R-FL) office will host Mobile Office Hours this week to assist constituents who were affected by Hurricane Idalia. These office hours offer constituents who do not live close to one of Senator Rubio’s eight regional offices a more...
Contemporary Amperex Technology Co. Ltd. (CATL), a company directly funded and supported by the Chinese Communist Party, continues to pose national security risks to the United States. This past spring, CATL batteries were installed at Camp Lejeune, North...
U.S. Senator Marco Rubio’s (R-FL) office will host in-person Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of Senator Rubio’s...
A mysterious respiratory illness is once again spreading in China. Until we know more about what could be a new pathogen, the United States must do everything possible to prevent the illness from reaching our shores. U.S. Senator Marco Rubio (R-FL) and colleagues sent...
Washington, D.C. — U.S. Senator Marco Rubio (R-FL) introduced the Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act of 2020 (S.4467), which encourages companies currently producing medical and pharmaceutical equipment abroad to relocate to the U.S. The bill would also enact a tax credit of federal income tax liability for wages and eligible pharmaceutical manufacturing facilities in economically distressed zones, including Puerto Rico.
In March, Rubio introduced bipartisan legislation to combat America’s supply chain risk and dependence on China for pharmaceuticals that builds off the plan he released in February. More than a year ago, Rubio issued a report detailing critical vulnerabilities in America’s medical supply chain, warning, “the U.S. runs the risk of losing important components of its medical supply chain to China’s government-backed industry.” Last year, Rubio warned in Modern Healthcare that when it comes to the threat China poses to the U.S. healthcare industry, we cannot afford to be complacent.
Representative Jenniffer González-Colón (R-PR) introduced companion legislation in the House of Representatives.
“The coronavirus pandemic has made it clear that we must rebuild our national manufacturing capacity, especially in our medical industry,” Rubio said. “For too long, our manufacturing capabilities have moved to China, impacting communities across our country, including Puerto Rico, which was once home to a strong manufacturing industry in the United States. I am proud to join Congresswoman González-Colón in this vital effort to rebuild our manufacturing capacity, especially in the economically marginalized areas that were most affected by the COVID-19 pandemic.”
“Puerto Rico has the capacity, labor, experience, and infrastructure to become a national hub for the production of medical equipment and medicines, attracting manufacturers and pharmaceutical companies located abroad,” González Colón said. “Thus, we secure the national supply chain and boost our economy with well-paying jobs. This is my bill that I am promoting along with Senator Marco Rubio and the reason why I have brought Rear Admiral Peter Brown and a delegation from the White House to visit various pharmaceutical plants in the Island.”
RUBIO, GONZÁLEZ-COLÓN PRESENTAN LEGISLACIÓN PARA REAVIVAR LA INDUSTRIA FARMACÉUTICA EN PUERTO RICO
Washington, DC – El senador estadounidense Marco Rubio (R-FL) presentó la Ley de Fabricación Médica, Desarrollo Económico y Sustentabilidad del 2020 (S.4467) la cual insta a las empresas que actualmente producen equipos médicos y farmacéuticos en el extranjero a trasladarse a EE.UU. Esta ley también promulgaria un crédito fiscal sobre los salarios y las instalaciones de fabricación farmacéutica elegibles en zonas económicamente afligidas, incluyendo a Puerto Rico.
En marzo de este año, el senador Rubio introdujo una legislación bipartidista para combatir el riesgo en la cadena de suministro de EE.UU. y la dependencia de nuestro país con China para productos farmacéuticos. Esa ley se basa en el plan que Rubio lanzó en febrero de este año. Hace más de un año, Rubio emitió un informe que detalla las vulnerabilidades críticas en la cadena de suministro médico de EE.UU., advirtiendo que “EE.UU. corre el riesgo de perder componentes importantes de su cadena de suministro médico a la industria respaldada por el gobierno de China”. El año pasado, Rubio advirtió que cuando se trata de la amenaza que China representa para la industria de la salud de EE. UU., no podemos permitirnos ser complacientes.
La representante Jenniffer González-Colón (R-PR) introdujo legislación compañera en la Cámara de Representantes.
“La pandemia del coronavirus ha dejado claro que debemos reconstruir nuestra capacidad de fabricación nacional, especialmente en nuestra industria médica”, Rubio dijo. “Por demasiado tiempo, nuestras capacidades de fabricación se han movido a China, impactando a las comunidades de todo nuestro país, incluyendo a Puerto Rico, que alguna vez fue el hogar de una industria manufacturera sólida en EE.UU. Me enorgullece unirme a la congresista González-Colón en este esfuerzo vital para reconstruir nuestra capacidad de fabricación, especialmente en las áreas económicamente marginadas que fueron más afectadas por la pandemia del COVID-19″.
“Puerto Rico tiene la capacidad, mano de obra, experiencia e infraestructura para convertirse en “hub” nacional de la producción de equipos médicos y medicamentos, atrayendo a manufactureras y farmacéuticas ubicadas en el extranjero”, González Colón dijo. “Así, aseguramos la cadena nacional de suministros e impulsamos nuestra economía con empleos bien remunerados. Esta es mi propuesta que estoy promoviendo junto al senador Marco Rubio y para la cual he traído además al contralmirante Peter Brown y delegación de la Casa Blanca para visitar varias plantas de la industria farmacéutica.”